Search clinical trials for: 300mg Gemcabene
Total 1597 results
-
Yuhan CorporationCompletedKnee OsteoarthritisKorea, Republic of
-
Quadram Institute BioscienceBiotechnology and Biological Sciences Research Council; The Danish Council...Completed
-
Tanta UniversityCompleted
-
Northwestern UniversityUniversity of Iowa; University of Rochester; Michael J. Fox Foundation for Parkinson...Completed
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
GenfitNaturalpha; SGS Aster S.A.S.CompletedCardiovascular Diseases | Metabolic Diseases | Diabetes Mellitus, Type 2 | Type 2 Diabetes | Dyslipidemia | ObeseFrance
-
9 Meters Biopharma, Inc.TerminatedShort Bowel SyndromeUnited States
-
Texas Tech University Health Sciences CenterCompleted
-
Hospital de Clinicas de Porto AlegreUnknownAttention Deficit/Hyperactivity DisorderBrazil
-
Medical University of ViennaTerminatedRheumatoid Arthritis | RemissionAustria
-
Chung Shan Medical UniversityGolden Biotechnology CorporationTerminated
-
Samyang Biopharmaceuticals CorporationSeoul National University HospitalCompletedHealthy, MaleKorea, Republic of
-
GlaxoSmithKlineCompleted
-
Relay Therapeutics, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Unresectable Solid Tumor | PIK3CA MutationUnited States, Spain, France, Italy
-
Novartis PharmaceuticalsCompletedGastrointestinal Stromal TumorsUnited States, France, Belgium, Germany
-
Duta Wacana Christian UniversityDexa Medica GroupRecruiting
-
PfizerCompletedBiological AvailabilityUnited States
-
Tongji HospitalWuhan Central Hospital; Wuhan Hospital of Traditional Chinese MedicineRecruitingAnkylosing Spondylitis (AS)China
-
University of SaskatchewanUnknown
-
Supernus Pharmaceuticals, Inc.RecruitingAttention-Deficit/Hyperactivity DisorderUnited States
-
University of Colorado, DenverActive, not recruitingAutism Spectrum DisorderUnited States
-
Shanghai Pharmaceuticals Holding Co., LtdCompleted
-
Egyptian Liver HospitalUnknownHepatitis C Virus Infection, Response to Therapy ofEgypt
-
Dawonmedax Co., Ltd.RecruitingRecurrent Glioblastoma | Recurrent High-grade Glioma | Recurrent Anaplastic Astrocytoma | Recurrent Anaplastic OligodendrogliomaKorea, Republic of
-
Joint Stock Company "Farmak"Completed
-
Instituto Mexicano del Seguro SocialCompleted
-
AllerganEnrolling by invitationIrritable Bowel SyndromeUnited States
-
Kresge Eye InstituteSuspendedFluorescein AngiographyUnited States
-
GlaxoSmithKlineCompletedBone Marrow TransplantationUnited States
-
Shanghai Pharmaceuticals Holding Co., LtdRecruitingLocally Advanced or Metastatic Breast CancerChina
-
Columbia UniversityResearch Foundation for Mental Hygiene, Inc.; Impact Research & Development...Not yet recruiting
-
University of OxfordOxford University Hospitals NHS TrustUnknown
-
Seoul National University Bundang HospitalPfizerUnknownProstate CancerKorea, Republic of
-
Columbia UniversityRecruitingAbdominal Cancer | Pelvic CancerUnited States
-
BioCryst PharmaceuticalsWithdrawn
-
Bright Future Pharmaceuticals Factory O/B Bright...Chinese University of Hong KongUnknown
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus Type 2Korea, Republic of
-
Hospital de Clinicas de Porto AlegreUnknownHeart Failure | AnemiaBrazil
-
Genor Biopharma Co., Ltd.Unknown
-
Daniel ClaassenRecruitingParkinson Disease | Multiple System Atrophy | Pure Autonomic Failure | Dementia With Lewy Bodies | Autonomic FailureUnited States
-
Ron PostumaCanadian Institutes of Health Research (CIHR)Completed
-
AstraZenecaActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum SensitiveChina, Malaysia
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
-
Samyang Biopharmaceuticals CorporationCompleted
-
Chong Kun Dang PharmaceuticalCholine Alfoscerate Re-evaluation Consortium (57 pharmaceutical companies)Not yet recruitingVascular Cognitive ImpairmentKorea, Republic of
-
University Hospital, GhentCompletedOvarian Cancer | Primary Peritoneal CancerBelgium
-
Peking Union Medical College HospitalUnknown
-
Nexgen Pharma, IncCompleted
-
The Faculty Hospital Na BulovceCompletedSmall Bowel Obstruction | Acute Appendicitis | Perforated Gastroduodenal UlcerCzech Republic